Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Old National Bancorp
ONB
$10.4B
| $48.5M | 0.01% |
3,280,509
+2,735,921
| +502% | +$42.1M |
|
1002
Lear
LEA
$8.16B
| $48.4M | 0.01% |
384,628
+357,101
| +1,297% | +$47.1M |
|
|
K
1003
CALL
DELISTED
Kellanova
K
| $48.4M | 0.01% |
722,070
+110,973
| +18% | +$7.21M |
|
1004
First Interstate BancSystem
FIBK
$3.7B
| $48.3M | 0.01% |
1,266,613
-543,510
| -30% | -$19.4M |
|
1005
CALL
CarMax
KMX
$8.33B
| $48.1M | 0.01% |
531,500
+28,600
| +6% | +$2.69M |
|
|
SGFY
1006
DELISTED
Signify Health, Inc.
SGFY
| $48.1M | 0.01% |
3,483,124
+352,626
| +11% | +$4.96M |
|
1007
CALL
iShares Semiconductor ETF
SOXX
$46.6B
| $47.9M | 0.01% |
411,000
+64,800
| +19% | +$8.74M |
|
|
AYX
1008
DELISTED
Alteryx Inc
AYX
| $47.8M | 0.01% |
987,920
+228,915
| +30% | +$13.7M |
|
1009
Ares Management
ARES
$32.1B
| $47.8M | 0.01% |
841,250
-151,150
| -15% | -$10.5M |
|
|
SIVB
1010
CALL
DELISTED
SVB Financial Group
SIVB
| $47.8M | 0.01% |
121,000
+38,700
| +47% | +$18.2M |
|
1011
PUT
GSK
GSK
$101B
| $47.8M | 0.01% |
878,240
+194,320
| +28% | +$10.7M |
|
1012
Synchrony
SYF
$25.8B
| $47.7M | 0.01% |
1,727,825
-1,727,830
| -50% | -$60M |
|
1013
SLB Ltd
SLB
$78.1B
| $47.7M | 0.01% |
1,332,587
+612,307
| +85% | +$25.5M |
|
|
VTYX
1014
DELISTED
Ventyx Biosciences
VTYX
| $47.6M | 0.01% |
3,891,328
-20,582
| -0.5% | -$308K |
|
1015
PUT
HSBC
HSBC
$358B
| $47.6M | 0.01% |
1,455,800
-530,000
| -27% | -$17.2M |
|
1016
CALL
Fair Isaac
FICO
$24B
| $47.5M | 0.01% |
118,600
+70,900
| +149% | +$28M |
|
1017
Delek US
DK
$4.12B
| $47.5M | 0.01% |
1,839,724
+390,447
| +27% | +$10.5M |
|
1018
CALL
Cameco
CCJ
$43.1B
| $47.4M | 0.01% |
2,257,000
+1,067,900
| +90% | +$26.9M |
|
1019
PUT
Equinix
EQIX
$105B
| $47.4M | 0.01% |
72,200
+1,900
| +3% | +$1.32M |
|
1020
CALL
HCA Healthcare
HCA
$89.8B
| $47.4M | 0.01% |
282,200
+59,300
| +27% | +$12.7M |
|
1021
CALL
Paycom
PAYC
$9.52B
| $47.3M | 0.01% |
168,900
+54,100
| +47% | +$16M |
|
1022
PUT
Suncor Energy
SU
$76.5B
| $47.3M | 0.01% |
1,347,500
+182,200
| +16% | +$6.63M |
|
1023
PagerDuty
PD
$876M
| $47.1M | 0.01% |
1,900,788
+964,916
| +103% | +$26.5M |
|
1024
CALL
HubSpot
HUBS
$12B
| $47.1M | 0.01% |
156,500
+26,500
| +20% | +$9.68M |
|
1025
CALL
Danaos Corp
DAC
$2.55B
| $47M | 0.01% |
745,400
+391,500
| +111% | +$31.4M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.